Help - Search - Members - Calendar
Full Version: Anemia
Online Medical Forum > Library Database Of Journals Publications Researches Category > Library Database Of Journals Publications Researches > Medicine Category > Internal Medicine Forum > Medicine Topics > Anemia
Pages: 1, 2, 3, 4, 5, 6, 7, 8
  1. Anemia: Nation's kidney doctors express concern over u.s. food and drug administration's health advisory on anemia drugs (0 replies)
  2. Anemia: Nation's kidney doctors express concern over u.s. food and drug administration's health advisory on anemia drugs (0 replies)
  3. Anemia: A review of the therapeutic agents used in the management of polycythaemia vera (0 replies)
  4. Anemia: Fda issues new warnings on widely used anemia drugs (0 replies)
  5. Anemia: Analysis: amgen's aranesp gets hit again (0 replies)
  6. Anemia: Levin, papantonio and mass torts made perfect, inc. announce aranesp, epogen and procrit added to seminar (0 replies)
  7. Anemia: Aplastic anemia: a contraindication? (0 replies)
  8. Anemia: Kidney docs warn on changing anemia care (0 replies)
  9. Anemia: New fda warnings for anemia drugs (0 replies)
  10. Anemia: New fda warnings for anemia drugs (0 replies)
  11. Anemia: Pyruvate kinase deficiency: the genotype-phenotype association. (0 replies)
  12. Anemia: Scrutiny of anemia drugs concerns affymax executives (0 replies)
  13. Anemia: Autoimmune hemolytic anemia following allogeneic hematopoietic stem cell transplantation in adult patients (0 replies)
  14. Anemia: Why erythropoetin has never made sense in cancer patients (to me) (0 replies)
  15. Anemia: Recombinant erythropoietin for chemotherapy-related anaemia: economic value and health-related quality-of-life assessment using direct utility elicitation and discrete choice experiment methods (0 replies)
  16. Anemia: Fda issues public health advisory on erythropoiesis-stimulating agents in the us (0 replies)
  17. Anemia: Fda strengthens safety information for erythropoiesis-stimulating agents (esas) (0 replies)
  18. Anemia: Phase ii study of amrubicin, 9-amino-anthracycline, in patients with advanced non-small-cell lung cancer: a west japan thoracic oncology group (wjtog) study (0 replies)
  19. Anemia: Anemia drug may harm some patients, fda says (0 replies)
  20. Anemia: Fda issues new warnings on anemia drugs
    (ap)     (0 replies)
  21. Anemia: Analysis: new warnings on anemia drugs (0 replies)
  22. Anemia: Fda issues new warnings on anemia drugs (0 replies)
  23. Anemia: Fda issues new warnings on anemia drugs (0 replies)
  24. Anemia: Fda issues new warnings on anemia drugs (0 replies)
  25. Anemia: Fda strengthens information on anemia drug safety (0 replies)
  26. Anemia: Fda strengthens information on anemia drug safety (0 replies)
  27. Anemia: Fda issues new warnings on anemia drugs (0 replies)
  28. Anemia: Fda issues new warnings on anemia drugs (0 replies)
  29. Anemia: Fda issues new warnings on anemia drugs (0 replies)
  30. Anemia: Fda issues new warnings on anemia drugs
    (ap)     (0 replies)
  31. Anemia: U.s. issues new warnings for anemia drugs (0 replies)
  32. Anemia: New warnings on amgen, j&j anemia drugs (0 replies)
  33. Anemia: Amgen, j&j anemia drugs to carry new warning: fda (0 replies)
  34. Anemia: Aplastic anaemia as an autoimmune complication of thymoma (0 replies)
  35. Anemia: Fda strengthens safety information for erythropoiesis-stimulating agents (esas) (0 replies)
  36. Anemia: Fanconi anemia (0 replies)
  37. Anemia: Immunotherapy does not prolong life when skin cancer spreads (0 replies)
  38. Anemia: New method to quantify erythrophagocytosis by autologous monocytes (0 replies)
  39. Anemia: Recombinant erythropoietin for chemotherapy-related anaemia: economic value and health-related quality-of-life assessment using direct utility elicitation and discrete choice experiment methods. (0 replies)
  40. Anemia: Trends in the hiv related hospital admissions in the haart era in barbados, 2004-2006 (0 replies)
  41. Anemia: Predictive value of discrimination indices in differential diagnosis of iron deficiency anemia and beta-thalassemia trait (0 replies)
  42. Anemia: Gastrointestinal plasmacytoma causing anemia in a patient with multiple myeloma (0 replies)
  43. Anemia: A case of silent giant cell arteritis involving the entire aorta, carotid artery and brachial artery screened by integrated pet/ct (0 replies)
  44. Anemia: Traditional and “new” cardiovascular risk markers and factors in pediatric dialysis patients (0 replies)
  45. Anemia: Phase i trial of radiochemotherapy with bendamustine in patients with recurrent squamous cell carcinoma of the head and neck (0 replies)
  46. Anemia: Combining erythropoiesis-stimulating agents for treatment of anemia in chronic kidney disease (0 replies)
  47. Anemia: Medblogs grand rounds 3:24 (0 replies)
  48. Anemia: Specific antibodies to moesin, a membrane-cytoskeleton linker protein, are frequently detected in patients with acquired aplastic anemia (0 replies)
  49. Anemia: Hypercharging tomatos with folate (0 replies)
  50. Anemia: Acute adrenal crisis after orthopedic surgery for pathologic fracture (0 replies)
  51. Anemia: Phase ii study of two dose schedules of c.e.r.a. (continuous erythropoietin receptor activator) in anemic patients with advanced non-small cell lung cancer (nsclc) receiving chemotherapy (0 replies)
  52. Anemia: I recently had a male patient with iron deficiency anaemia and a negative faecal occult blood result. what is the incidence of a false negative f.o.b. in these circumstances? (0 replies)
  53. Anemia: Zinc protoporphyrin, a useful parameter to address hyperferritinemia (0 replies)
  54. Anemia: Immunotherapy does not prolong life when skin cancer spreads (0 replies)
  55. Anemia: Immunotherapy does not prolong life when skin cancer spreads (0 replies)
  56. Anemia: Dihydroartemisinin-piperaquine versus artesunate-amodiaquine: superior efficacy and posttreatment prophylaxis against multidrug-resistant plasmodium falciparum and plasmodium vivax malaria (0 replies)
  57. Anemia: Cardiac hypertrophy in anion exchanger 1-null mutant mice with severe hemolytic anemia (0 replies)
  58. Anemia: Infection as a cause of early relapse in patients recovering from thrombotic thrombocytopenic purpura (0 replies)
  59. Anemia: [hepatitis] rate and predictors of treatment prescription for hepatitis c (0 replies)
  60. Anemia: Nist 'micro-rack' measures cell mechanical properties (0 replies)
  61. Anemia: A randomized trial comparing immediate versus delayed treatment of anemia with once-weekly epoetin alfa in patients with non-small cell lung cancer scheduled to receive first-line chemotherapy. (0 replies)
  62. Anemia: Two fixed-dose artemisinin combinations for drug-resistant falciparum and vivax malaria in papua, indonesia: an open-label randomised comparison. (0 replies)
  63. Anemia: Clinical focus conference advance registration ends soon (0 replies)
  64. Anemia: Unexplained anaemia in older persons is characterised by low erythropoietin and low levels of pro-inflammatory markers (0 replies)
  65. Anemia: Loss of expression of fancd2 protein in sporadic and hereditary breast cancer (0 replies)
  66. Anemia: A comparison of haemophagocytic syndrome signs in aortic aneurysm and angina pectoris cases at postoperative death: hps diagnosis and prediction (0 replies)
  67. Anemia: [miscellaneous] an unusual case of anaemia and dyspnoea (0 replies)
  68. Anemia: Nist 'micro-rack' measures cell mechanical properties (0 replies)
  69. Anemia: Researchers run their fingers through wool looking for solutions (0 replies)
  70. Anemia: Chemoimmunotherapy versus chemotherapy for metastatic malignant melanoma (0 replies)
  71. Anemia: Correction of anemia in chronic renal failure (0 replies)
  72. Anemia: Infectious disease morbidity among young hiv-1-exposed but uninfected infants in latin american and caribbean countries: the national institute of child health and human development international site development initiative perinatal study (0 replies)
  73. Anemia: Childhood helicobacter pylori infection and growth impairment in developing countries: a vicious cycle? (0 replies)
  74. Anemia: Marked hyperbilirubinemia associated with the heme oxygenase-1 gene promoter microsatellite polymorphism in a boy with autoimmune hemolytic anemia (0 replies)
  75. Anemia: Citrin deficiency: a novel cause of failure to thrive that responds to a high-protein, low-carbohydrate diet (0 replies)
  76. Anemia: High-throughput screening identifies novel agents eliciting hypersensitivity in fanconi pathway-deficient cancer cells (0 replies)
  77. Anemia: Gemcitabine plus oxaliplatin (gemox) in patients with advanced hepatocellular carcinoma (hcc) (0 replies)
  78. Anemia: Not milk? (0 replies)
  79. Anemia: The coexistence of other micronutrient deficiencies in anaemic adolescent schoolgirls in rural bangladesh (0 replies)
  80. Anemia: Correspondence: an ongoing study of anemia correction in chronic kidney disease (0 replies)
  81. Anemia: Correspondence: chronic kidney disease, anemia, and epoetin (0 replies)
  82. Anemia: Which anemic patients should be referred for colonoscopy? (0 replies)
  83. Anemia: Ventricular structure and function in hypertensive participants with heart failure and a normal ejection fraction: the cardiovascular health study (0 replies)
  84. Anemia: Prediction of outcome in adults with severe falciparum malaria: a new scoring system (0 replies)
  85. Anemia: Recruitment temporarily suspended into c.e.r.a. phase ii oncology trial (0 replies)
  86. Anemia: Original investigation: screening for occult renal disease (scored): a simple prediction model for chronic kidney disease (0 replies)
  87. Anemia: Reference values for the erythrocytic profile of anak 2000 broilers and lohmann brown pullets in nsukka, eastern nigeria (0 replies)
  88. Anemia: Hodgkin lymphoma accompanied by aplastic anemia and polyclonal expansion of large granular lymphocytes (0 replies)
  89. Anemia: Administration of exogenous erythropoietin β affects lipid peroxidation and serum paraoxonase-1 activity and concentration in predialysis patients with chronic renal disease and anaemia (0 replies)
  90. Anemia: Nigeria: fg urged to research on sickle cell (0 replies)
  91. Anemia: The canadian celiac health survey (0 replies)
  92. Anemia: Hodgkin lymphoma accompanied by aplastic anemia and polyclonal expansion of large granular lymphocytes. (0 replies)
  93. Anemia: Randomized phase ii three-arm trial with three platinum-based doublets in metastatic non-small-cell lung cancer. an italian trials in medical oncology study (0 replies)
  94. Anemia: Compromised fanconi anemia response due to brca1 deficiency in cisplatin-sensitive head and neck cancer cell lines. (0 replies)
  95. Anemia: [preview] the fanconi anemia signalosome anchor (0 replies)
  96. Anemia: Dominican republic: flour, sugar - vehicles of food fortification plan (0 replies)
  97. Anemia: Features of iron deficiency anemia without increment in soluble transferrin receptor concentration (0 replies)
  98. Anemia: Is early treatment of anaemia with epoetin-{alpha} beneficial to pre-dialysis chronic kidney disease patients? results of a multicentre, open-label, prospective, randomized, comparative group trial (0 replies)
  99. Anemia: Prevalence and predictors of epoetin hyporesponsiveness in chronic kidney disease patients (0 replies)
  100. Anemia: Reply: potential mode of action of l-carnitine on uraemic anaemia (0 replies)
  101. Anemia: Study looking at the effect of erythropoietin on quality of life in patients with nsclc and disease-related anaemia stopped early due to higher survival in the placebo group (0 replies)
  102. Anemia: Newsdesk: off-label use of aranesp linked to increased mortality risk (0 replies)
  103. Anemia: Pregnancy after bone marrow transplantation in fanconi anaemia: response to dalle et al (0 replies)
  104. Anemia: Off-label use of aranesp linked to increased mortality risk (0 replies)
  105. Anemia: Retrospective nationwide survey of japanese patients with transfusion-dependent mds and aplastic anemia highlights the negative impact of iron overload on morbidity/mortality (0 replies)
  106. Anemia: Pregnancy after bone marrow transplantation in fanconi anaemia (0 replies)
  107. Anemia: [on the ajr digital viewbox] hemolytic anemia caused by iatrogenic arteriovenous iliac fistula and successfully treated by endovascular stent-graft placement (0 replies)
  108. Anemia: Unrelated donor bone marrow transplantation for the treatment of fanconi anemia (0 replies)
  109. Anemia: Unrelated donor bone marrow transplantation for the treatment of fanconi anemia (0 replies)
  110. Anemia: Effect of haematinic supplementation and malaria prevention on maternal anaemia and malaria in western kenya (0 replies)
  111. Anemia: Obtain skills to manage anemia in the critically ill and injured during clinical focus (0 replies)
  112. Anemia: Erythropoiesis-stimulating agent (aranesp) (0 replies)
  113. Anemia: Us fda issues alert stating erythropoiesis stimulating agents should not be used for treatment of anaemia in cancer patients not receiving chemotherapy (0 replies)
  114. Anemia: Anemia and heart failure (0 replies)
  115. Anemia: Invasive fungal infection in systemic lupus erythematosus: an analysis of 15 cases and a literature review (0 replies)
  116. Anemia: Influence of leukocytapheresis therapy for ulcerative colitis on anemia and hemodynamics (0 replies)
  117. Anemia: Bilateral orbital tumor formation and isolated facial palsy in waldenstrom’s macroglobulinemia (0 replies)
  118. Anemia: Small-bowel tumors detected by wireless capsule endoscopy (0 replies)
  119. Anemia: Hemoglobin variation and blood transfusion rates in patients affected by locally advanced cervical cancer undergoing neo-adjuvant chemotherapy followed by radical surgery: the role of erythropoietic growth factors. (0 replies)
  120. Anemia: Increased plasma malondialdehyde and fructosamine in anemic h pylori infected patients: effect of treatment. (49 replies)
  121. Anemia: Volume 195, number 6: bacteremia in malawian children with severe malaria: prevalence, etiology, hiv coinfection, and outcome (0 replies)
  122. Anemia: Metabolic disorders in patients with chronic kidney failure. (0 replies)
  123. Anemia: Improvement of criteria for refractory cytopenia with multilineage dysplasia according to the who classification based on prognostic significance of morphological features in patients with refractory anemia according to the fab classification (48 replies)
  124. Anemia: Hematopoietic stem-cell contribution to ectopic skeletogenesis (0 replies)
  125. Anemia: Center effect found in anemia management of dialysis patients (0 replies)
  126. Anemia: Natural history of anemia associated with interferon/ribavirin therapy for patients with hiv/hcv coinfection (0 replies)
  127. Anemia: Oxaliplatin-induced hemolytic anemia during adjuvant treatment of a patient with colon cancer: a case report. (0 replies)
  128. Anemia: Human metabolism through a computational approach (0 replies)
  129. Anemia: Refractory anaemia with excess of blasts in transformation re-evaluated with the who criteria: identification of subgroups with different survival (0 replies)
  130. Anemia: Anemia-induced neurocognitive dysfunction: is oxygen the only player? (0 replies)
  131. Anemia: Anemia-induced neurocognitive dysfunction: is oxygen the only player? (0 replies)
  132. Anemia: Variable aetiologies contributing to the anaemia of systolic heart failure are important to individual patient management (0 replies)
  133. Anemia: Anaemia in chronic heart failure is not only related to impaired renal perfusion and blunted erythropoietin production, but to fluid retention as well (0 replies)
  134. Anemia: [pediatric oncology] phase ii trial of irinotecan in children with relapsed or refractory rhabdomyosarcoma: a joint study of the french society of pediatric oncology and the united kingdom children's cancer study group (0 replies)
  135. Anemia: Amgen warns of mortality risk for off-label use of aranesp (0 replies)
  136. Anemia: Amgen warns of mortality risk for off-label use of aranesp (0 replies)
  137. Anemia: Aranesp ineffective in anemia not caused by chemotherapy (0 replies)
  138. Anemia: The target hemoglobin in patients with chronic kidney disease (0 replies)
  139. Anemia: Correlation between levels of tnf-α and il-6 and hematological involvement in sle egyptian patients with lupus nephritis (0 replies)
  140. Anemia: On the horizon future medicines, continuous erythropoietin receptor activator (cera) for anaemia of chronic kidney disease (0 replies)
  141. Anemia: Greater caution on anemia drugs seen after deaths (0 replies)
  142. Anemia: Industry sluggish in race to churn out new drugs (0 replies)
  143. Anemia: Intravascular fluorocarbon-stabilized microbubbles protect against fatal anemia in rats (0 replies)
  144. Anemia: Fda medwatch notifies healthcare professionals of study results showing increased mortality with aranesp (darbepoetin) (0 replies)
  145. Anemia: Liver cell death and anemia in wilson disease involve acid sphingomyelinase and ceramide (0 replies)
  146. Anemia: Achalasia and thyroid disease. (0 replies)
  147. Anemia: Affymax presents results from ongoing phase 2 clinical trial of hematide(tm) in anemic cancer ... (97 replies)
  148. Anemia: Looking ahead with pubdrug (0 replies)
  149. Anemia: New commentary added: sinclair l (2007) (0 replies)
  150. Anemia: Uptake of anti-anemic substance ferric-sorbitol-citrate by normal and malignant cells and its effects on expression of transferrin receptor 1 and ferritin (0 replies)
This is a "lo-fi" version of our main content. To view the full version with more information, formatting and images, please click here.
Invision Power Board © 2001-2009 Invision Power Services, Inc.